Altimmune, Inc. (ALT) Tops Q3 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Trump On Fed: Warsh Is Fantastic
• Meridian Holdings Inc. (MRDN) Tops Q2 EPS by 2c
• V.F. Corp. (VFC) call put ratio 1 call to 2.8 puts as share price down 17.6%